Thursday, November 12, 2009
Check us out!
What an exciting week! We had a film crew from Fox 17 come in and film a new commercial! Look for it starting Monday the 16th! Let us know what you think.
Wednesday, November 4, 2009
2009 Toy Drive
Click on the picture below to learn more about our 2009 Toy drive.
This is a wish list of items requested by patients at the hospial:
Jenga games
Board and card games
Puzzles
Light and sound toddler toys
Craft supplies
Hand held electronic games
Coloring books and crayons
Educational books
Writing Journals
Game Boy games
Leap Frog Leapster Games
Push button/ sound books
Magnetic Maze boards
Magic Doodle and Doodle Pro
Realistic plastic food
Nintendo DS games
Children's Videos
V-tech toys
I Spy books
Groovey Girls
This is a wish list of items requested by patients at the hospial:
Jenga games
Board and card games
Puzzles
Light and sound toddler toys
Craft supplies
Hand held electronic games
Coloring books and crayons
Educational books
Writing Journals
Game Boy games
Leap Frog Leapster Games
Push button/ sound books
Magnetic Maze boards
Magic Doodle and Doodle Pro
Realistic plastic food
Nintendo DS games
Children's Videos
V-tech toys
I Spy books
Groovey Girls
Monday, October 19, 2009
Flu shot
Please, please, please find all the information you can find before injecting this very toxic poison into your body. Below I have put a video of a young woman who's life has been permanently disabled by one shot.
Look back over your life and count how many times you've actually had the "flu". Personally, maybe, twice. Most people catch a rhinovirus which is responsible for the "common cold" NOT the flu.
Ways to prevent the common cold AND the flu:
1. Wash your hands
2. Take a good multivitamin
3. Get plenty of rest/sleep
4. Keep your spine clear of interference (there is a direct link between your nervous system and immune system)
5. Exercise
6. Stay away from eating sugar and processed foods.
Following some simple guidelines will help ensure you do not come down with an illness. If you do catch something follow the same advice as above. Drink plenty of fluids. Allow your body to run a higher temperature. Viruses live in a very narrow temperature range. The fluctuations in body temperature are what actually kills the virus. Fever reducers prolong the illness. Antibiotics DO NOT WORK against a virus!
For those who do catch the flu, it will not be fun. You'll miss work, school, parties, etc... But, your body is designed to fight it and develop resistance against that particular flu strain. Next week you'll be fine. Granted, some people are drastically affected by the actual flu virus, .01% of Americans. For those, I am sorry. But I feel the vaccine does much more damage on a much wider scale than the virus could affect.
Look back over your life and count how many times you've actually had the "flu". Personally, maybe, twice. Most people catch a rhinovirus which is responsible for the "common cold" NOT the flu.
Ways to prevent the common cold AND the flu:
1. Wash your hands
2. Take a good multivitamin
3. Get plenty of rest/sleep
4. Keep your spine clear of interference (there is a direct link between your nervous system and immune system)
5. Exercise
6. Stay away from eating sugar and processed foods.
Following some simple guidelines will help ensure you do not come down with an illness. If you do catch something follow the same advice as above. Drink plenty of fluids. Allow your body to run a higher temperature. Viruses live in a very narrow temperature range. The fluctuations in body temperature are what actually kills the virus. Fever reducers prolong the illness. Antibiotics DO NOT WORK against a virus!
For those who do catch the flu, it will not be fun. You'll miss work, school, parties, etc... But, your body is designed to fight it and develop resistance against that particular flu strain. Next week you'll be fine. Granted, some people are drastically affected by the actual flu virus, .01% of Americans. For those, I am sorry. But I feel the vaccine does much more damage on a much wider scale than the virus could affect.
Tuesday, September 29, 2009
Cervical Cancer Vaccine
British Schoolgirl Dies After Vaccination
AOL / Wire Services
(Sept. 28) - A 14-year-old British schoolgirl died Monday, shortly after receiving a cervical cancer vaccination. Local health authorities launched an "urgent" investigation but say a link between the death and the drug has not been established.
The teenager was administered Cervarix, a vaccine for the human papillomavirus (HPV), at her school in Conventry, England. She became sick soon after and was sent to a hospital where she died.
"No link can be made between the death and the vaccine until all the facts are known and a post-mortem takes place," said Dr Caron Grainger, the joint director of public health for NHS (National Health Service) Coventry. "We are conducting an urgent and full investigation into the events surrounding this tragedy."
At least three other girls at the school who received the shot also reported mild symptoms, such as dizziness and nausea, but were not hospitalized.
The batch of Cervarix vaccine used at the school has been quarantined.
Cervarix, manufactured by UK-headquartered GlaxoSmithKline, has been used for the past year in Britain's national immunization program. It is estimated that about a million girls have already safely received the vaccine. It defends against two HPV strains which cause about 70 percent of cervical cancer cases.
In the United States, a panel of vaccine experts at the FDA voted overwhelmingly earlier this month that Cervarix appears safe and effective for girls and women ages 10 to 25. If the FDA follows the group's advice, as it usually does, Glaxo would begin competing against Merck's Gardasil, which has controlled the U.S. market since 2006.
AOL / Wire Services
(Sept. 28) - A 14-year-old British schoolgirl died Monday, shortly after receiving a cervical cancer vaccination. Local health authorities launched an "urgent" investigation but say a link between the death and the drug has not been established.
The teenager was administered Cervarix, a vaccine for the human papillomavirus (HPV), at her school in Conventry, England. She became sick soon after and was sent to a hospital where she died.
"No link can be made between the death and the vaccine until all the facts are known and a post-mortem takes place," said Dr Caron Grainger, the joint director of public health for NHS (National Health Service) Coventry. "We are conducting an urgent and full investigation into the events surrounding this tragedy."
At least three other girls at the school who received the shot also reported mild symptoms, such as dizziness and nausea, but were not hospitalized.
The batch of Cervarix vaccine used at the school has been quarantined.
Cervarix, manufactured by UK-headquartered GlaxoSmithKline, has been used for the past year in Britain's national immunization program. It is estimated that about a million girls have already safely received the vaccine. It defends against two HPV strains which cause about 70 percent of cervical cancer cases.
In the United States, a panel of vaccine experts at the FDA voted overwhelmingly earlier this month that Cervarix appears safe and effective for girls and women ages 10 to 25. If the FDA follows the group's advice, as it usually does, Glaxo would begin competing against Merck's Gardasil, which has controlled the U.S. market since 2006.
Wednesday, July 29, 2009
Unbelievable Poisoning of Our Children
Source: MedPage Today
No Safety and Efficacy Testing Required Prior to Mass Vaccination FDA announces that vaccine need only work in less than 3 out of 10 recipients
The FDA is likely to approve 2009 H1N1 (swine flu) vaccines before trial data can prove their safety or effectiveness against the virus. This announcement comes despite the fact that the 1976 mass swine flu vaccination program resulted in thousands of vaccine injuries, numerous deaths and $3.5 billion in damage claims by U.S. citizens.
The FDA also announced that a vaccine will be accepted if it creates antibodies in 4 out of 10 recipients (40%), with at least 70 percent of those 4 achieving an antibody level believed to provide benefit. This means that an acceptable vaccine candidate would provide “protection” for 28% of vaccine recipients (70% of the 40%), or less than 3 in 10 recipients. The requirement drops to 18% efficacy for those over 65 years of age (60% of 30%).
Alarming as this is, approving a vaccine without safety and immunogenicity (efficacy) data is not uncommon, FDA officials said during a daylong meeting of the Vaccines and Related Biological Products Advisory Committee. The committee met to hear updates on H1N1 trials from the FDA, NIH, and the five companies that are applying for FDA approval of pandemic H1N1 vaccines.
The FDA approves seasonal influenza vaccines every year using its "strain change" process, in which it doesn't require vaccine manufacturers to provide safety and efficacy data. What is different about how the FDA is likely to handle approval for a vaccine for pandemic H1N1, however, is that the agency doesn't normally approve vaccines while major clinical trials of safety and immunogenicity are ongoing.
Norman Baylor, PhD, director of FDA's Office of Vaccines Research and Review, explained the FDA's probable decision to go ahead with the “simplified approval process”, rather than its customary demands for compelling safety and immunogenicity data.
The government expects Novartis, Sanofi Pasteur, CSL, and GlaxoSmithKline to supply inactivated H1N1 vaccines to the U.S. market, while MedImmune will produce a live attenuated H1N1 vaccine, according to the document.
The FDA said it would like the sponsors of the study to perform double-blind or observer-blinded studies in which patients are administered two doses of the vaccine, 21 days apart. Manufacturers should stratify their patients into four age groups: infants and toddlers, ages 3 to 9, 18- to 64-year-olds, and older than 65. The FDA did not request an adolescent group because those data can be interpolated from the other age groups, the document said. It also didn't specify a study protocol for babies less than six months, because such studies will have to be designed to evaluate the entire series of infant vaccinations.
The FDA said that 100 patients in each arm of the trials "is sufficient to provide a description assessment of immunogenicity with a reasonable degree of confidence in that estimate." If a control arm is used, it should contain at least 25 patients.
The FDA recommended that patients should be followed for six months after the second vaccination to monitor for serious adverse events, and for one year if the second vaccine contains an adjuvant, the FDA said.
The vaccine will be considered as having an immunogenic response if:
* The lower bound of the two-sided 95% confidence interval for the percentage of subjects achieving seroconversion for H1 antibody should meet or exceed 40%, or 30% for those over 65.
* The lower bound of the two-sided 95% CI for the percentage of subjects achieving an H1 antibody titer more than or equal to 1:40 should meet or exceed 70%, or 60% for those over 65.
The FDA will be working with manufacturers and government agencies to coordinate surveillance plans, after the vaccines are administered, according to the briefing document. It is expected that the National Institutes of Health will also sponsor some H1N1 vaccine studies, and the agency will present its plan to the advisory panel.
Having a licensed vaccine doesn't mean that an immunization program will kick-off immediately -- that call has to come from the Secretary of Health and Human Services (HHS). But given the prediction that H1N1 infection rates will pick up this fall, immunization programs are likely to begin before safety and immunological data collection is completed. That trial data will begin trickling in during August and continue through early 2010. The World Health Organization (WHO) and the NIH have said they want to start vaccinating people by mid-October.
Of the five companies applying for FDA approval -- Novartis, Sanofi- Pasteur, CSL Biotherapies, GlaxoSmithKline, and MedImmune -- only CSL has already started human trials. The Australian company, which provides seasonal flu vaccines to the U.S., inoculated its first human trial participant Wednesday. Meanwhile, the NIH announced it was set to begin clinical trials in the United States of vaccines made by Sanofi-Pasteur and CSL.
Because an immunization program will likely run at the same time as the trial, the FDA said it would issue updates as the trials answer key questions. They include whether two shots are better than one, and how the vaccine interacts with seasonal flu shots. "That's the harder decision -- how those immunization decisions will be made as that data comes in," said Dr. Baylor.
There's a chance the early data will show the vaccine is ineffective at stimulating an immune response. If that's the case, the FDA might have to issue an "emergency use authorization" for an oil-in-water adjuvant that sparks a stronger reaction in the immune system, but causes more side effects.
There are currently no licensed influenza vaccines that contain an adjuvant, and Dr. Baylor said he couldn't recall a time when the FDA issued an emergency use authorization for a vaccine.
In other words, if the experimental vaccine doesn’t work, the FDA anticipates experimenting by adding an adjuvant, also not safety and efficacy tested. Some doctors and scientists have suggested that adjuvants in vaccines may be responsible for many of the side effects, including Autism, experienced after vaccination through what has been described as “brain fire”.
Adjuvants are chemical added to vaccines that “rev up” the body’s immune system response to the virus in the vaccine. This “revving up” of the brain and central nervous system of developing children has been suggested as a possible cause of the skyrocketing numbers of vaccine injuries.
Two companies, GlaxoSmithKline and Novartis, are applying for approval for vaccines that contain oil-in-water adjuvants. The NIH is also conducting a trial of an adjuvant-enhanced vaccine. The panel's consumer representative said if the FDA does issue an emergency use authorization for an adjuvanted vaccine, she would prefer as little adjuvant as possible to avoid side effects.
Another panelist, Theodore Eickhoff, MD, an infectious disease specialist at the University of Colorado, said adjuvanted flu vaccines have been used for a decade in Europe and have not been shown to harm vulnerable populations, such as children.
"I don't want FDA . . . to walk away from this meeting thinking we're all scared of adjuvanted vaccines," Dr. Eickhoff said. "Some of us are. I'm not. I'm delighted the options are there."
The government has already purchased a supply of 120 million adjuvant doses that it will add to its antigen supply if it there is a shortage of the vaccine, or if the standard versions are shown to be ineffective. The panel did not reach consensus on whether patients should receive one or two doses. Once trial data becomes available, it will be more apparent whether doses given 21 days apart are superior to a single dose, members indicated.
The committee agreed that pregnant women should be immunized, but did not recommend inoculation of babies under six months old. The chairman of the committee, a pediatrician, said the FDA might want to prepare for an infant vaccination program if surveillance data indicate a wider pandemic than expected. "I don't think it would be a bad idea to have a game plan to immunize babies under six months in case of emergency," said John Modlin, MD, a pediatrician at Dartmouth-Hitchcock Medical Center in Lebanon, N.H.
Any emergency plan to immunize babies would seem to contradict the statements in the FDA announcement that it didn't specify a study protocol for babies less than six months, because such studies will have to be designed to evaluate the entire series of infant vaccinations.
FDA officials also told the panel that vaccine manufactures are getting only one-third as much antigen from the pandemic H1N1 strain as they normally get from the seasonal flu virus. That might mean vaccine makers won't be able to make as many doses as they planned.
The CDC's Advisory Committee on Immunization Practices will meet in Atlanta next week to vote on which populations should be vaccinated first, among other issues.
It is this author’s opinion that compelling safety and immunogenicity (efficacy) should be of paramount importance prior to injecting hundreds of millions of people with this new, unproven chemical.
Clinical trials involving 400 participants (4 arms of 100 patients each) are woefully inadequate to insure safety and efficacy.
Adding adjuvant to flu vaccines without any long term studies on the possible harmful effects under an “emergency use authorization” is misguided and dangerous.
And most importantly, we must question the wisdom of putting hundreds of millions of people at risk by use of an experimental vaccine in order to possibly prevent what amounts to a bad cold, which is rarely life threatening or fatal.
No Safety and Efficacy Testing Required Prior to Mass Vaccination FDA announces that vaccine need only work in less than 3 out of 10 recipients
The FDA is likely to approve 2009 H1N1 (swine flu) vaccines before trial data can prove their safety or effectiveness against the virus. This announcement comes despite the fact that the 1976 mass swine flu vaccination program resulted in thousands of vaccine injuries, numerous deaths and $3.5 billion in damage claims by U.S. citizens.
The FDA also announced that a vaccine will be accepted if it creates antibodies in 4 out of 10 recipients (40%), with at least 70 percent of those 4 achieving an antibody level believed to provide benefit. This means that an acceptable vaccine candidate would provide “protection” for 28% of vaccine recipients (70% of the 40%), or less than 3 in 10 recipients. The requirement drops to 18% efficacy for those over 65 years of age (60% of 30%).
Alarming as this is, approving a vaccine without safety and immunogenicity (efficacy) data is not uncommon, FDA officials said during a daylong meeting of the Vaccines and Related Biological Products Advisory Committee. The committee met to hear updates on H1N1 trials from the FDA, NIH, and the five companies that are applying for FDA approval of pandemic H1N1 vaccines.
The FDA approves seasonal influenza vaccines every year using its "strain change" process, in which it doesn't require vaccine manufacturers to provide safety and efficacy data. What is different about how the FDA is likely to handle approval for a vaccine for pandemic H1N1, however, is that the agency doesn't normally approve vaccines while major clinical trials of safety and immunogenicity are ongoing.
Norman Baylor, PhD, director of FDA's Office of Vaccines Research and Review, explained the FDA's probable decision to go ahead with the “simplified approval process”, rather than its customary demands for compelling safety and immunogenicity data.
The government expects Novartis, Sanofi Pasteur, CSL, and GlaxoSmithKline to supply inactivated H1N1 vaccines to the U.S. market, while MedImmune will produce a live attenuated H1N1 vaccine, according to the document.
The FDA said it would like the sponsors of the study to perform double-blind or observer-blinded studies in which patients are administered two doses of the vaccine, 21 days apart. Manufacturers should stratify their patients into four age groups: infants and toddlers, ages 3 to 9, 18- to 64-year-olds, and older than 65. The FDA did not request an adolescent group because those data can be interpolated from the other age groups, the document said. It also didn't specify a study protocol for babies less than six months, because such studies will have to be designed to evaluate the entire series of infant vaccinations.
The FDA said that 100 patients in each arm of the trials "is sufficient to provide a description assessment of immunogenicity with a reasonable degree of confidence in that estimate." If a control arm is used, it should contain at least 25 patients.
The FDA recommended that patients should be followed for six months after the second vaccination to monitor for serious adverse events, and for one year if the second vaccine contains an adjuvant, the FDA said.
The vaccine will be considered as having an immunogenic response if:
* The lower bound of the two-sided 95% confidence interval for the percentage of subjects achieving seroconversion for H1 antibody should meet or exceed 40%, or 30% for those over 65.
* The lower bound of the two-sided 95% CI for the percentage of subjects achieving an H1 antibody titer more than or equal to 1:40 should meet or exceed 70%, or 60% for those over 65.
The FDA will be working with manufacturers and government agencies to coordinate surveillance plans, after the vaccines are administered, according to the briefing document. It is expected that the National Institutes of Health will also sponsor some H1N1 vaccine studies, and the agency will present its plan to the advisory panel.
Having a licensed vaccine doesn't mean that an immunization program will kick-off immediately -- that call has to come from the Secretary of Health and Human Services (HHS). But given the prediction that H1N1 infection rates will pick up this fall, immunization programs are likely to begin before safety and immunological data collection is completed. That trial data will begin trickling in during August and continue through early 2010. The World Health Organization (WHO) and the NIH have said they want to start vaccinating people by mid-October.
Of the five companies applying for FDA approval -- Novartis, Sanofi- Pasteur, CSL Biotherapies, GlaxoSmithKline, and MedImmune -- only CSL has already started human trials. The Australian company, which provides seasonal flu vaccines to the U.S., inoculated its first human trial participant Wednesday. Meanwhile, the NIH announced it was set to begin clinical trials in the United States of vaccines made by Sanofi-Pasteur and CSL.
Because an immunization program will likely run at the same time as the trial, the FDA said it would issue updates as the trials answer key questions. They include whether two shots are better than one, and how the vaccine interacts with seasonal flu shots. "That's the harder decision -- how those immunization decisions will be made as that data comes in," said Dr. Baylor.
There's a chance the early data will show the vaccine is ineffective at stimulating an immune response. If that's the case, the FDA might have to issue an "emergency use authorization" for an oil-in-water adjuvant that sparks a stronger reaction in the immune system, but causes more side effects.
There are currently no licensed influenza vaccines that contain an adjuvant, and Dr. Baylor said he couldn't recall a time when the FDA issued an emergency use authorization for a vaccine.
In other words, if the experimental vaccine doesn’t work, the FDA anticipates experimenting by adding an adjuvant, also not safety and efficacy tested. Some doctors and scientists have suggested that adjuvants in vaccines may be responsible for many of the side effects, including Autism, experienced after vaccination through what has been described as “brain fire”.
Adjuvants are chemical added to vaccines that “rev up” the body’s immune system response to the virus in the vaccine. This “revving up” of the brain and central nervous system of developing children has been suggested as a possible cause of the skyrocketing numbers of vaccine injuries.
Two companies, GlaxoSmithKline and Novartis, are applying for approval for vaccines that contain oil-in-water adjuvants. The NIH is also conducting a trial of an adjuvant-enhanced vaccine. The panel's consumer representative said if the FDA does issue an emergency use authorization for an adjuvanted vaccine, she would prefer as little adjuvant as possible to avoid side effects.
Another panelist, Theodore Eickhoff, MD, an infectious disease specialist at the University of Colorado, said adjuvanted flu vaccines have been used for a decade in Europe and have not been shown to harm vulnerable populations, such as children.
"I don't want FDA . . . to walk away from this meeting thinking we're all scared of adjuvanted vaccines," Dr. Eickhoff said. "Some of us are. I'm not. I'm delighted the options are there."
The government has already purchased a supply of 120 million adjuvant doses that it will add to its antigen supply if it there is a shortage of the vaccine, or if the standard versions are shown to be ineffective. The panel did not reach consensus on whether patients should receive one or two doses. Once trial data becomes available, it will be more apparent whether doses given 21 days apart are superior to a single dose, members indicated.
The committee agreed that pregnant women should be immunized, but did not recommend inoculation of babies under six months old. The chairman of the committee, a pediatrician, said the FDA might want to prepare for an infant vaccination program if surveillance data indicate a wider pandemic than expected. "I don't think it would be a bad idea to have a game plan to immunize babies under six months in case of emergency," said John Modlin, MD, a pediatrician at Dartmouth-Hitchcock Medical Center in Lebanon, N.H.
Any emergency plan to immunize babies would seem to contradict the statements in the FDA announcement that it didn't specify a study protocol for babies less than six months, because such studies will have to be designed to evaluate the entire series of infant vaccinations.
FDA officials also told the panel that vaccine manufactures are getting only one-third as much antigen from the pandemic H1N1 strain as they normally get from the seasonal flu virus. That might mean vaccine makers won't be able to make as many doses as they planned.
The CDC's Advisory Committee on Immunization Practices will meet in Atlanta next week to vote on which populations should be vaccinated first, among other issues.
It is this author’s opinion that compelling safety and immunogenicity (efficacy) should be of paramount importance prior to injecting hundreds of millions of people with this new, unproven chemical.
Clinical trials involving 400 participants (4 arms of 100 patients each) are woefully inadequate to insure safety and efficacy.
Adding adjuvant to flu vaccines without any long term studies on the possible harmful effects under an “emergency use authorization” is misguided and dangerous.
And most importantly, we must question the wisdom of putting hundreds of millions of people at risk by use of an experimental vaccine in order to possibly prevent what amounts to a bad cold, which is rarely life threatening or fatal.
Monday, July 27, 2009
Final Tally on Food Drive
We received 1269 pounds of food. and $70 cash. That is 10% of what the USPS donated in their recent food drive.
Interesting facts:
that is more than 1/2 ton
5 baby elephants
2 full grown dolphins
a male full grown alligator
a full grown quarter horse
or a Geo Metro!
When converting it to oreo's that 3,384,003 oreo's. Which equals 88,818.983 feet or 83 1/2 Effile towers :) or 59.9 Sears tower's (oops sorry Willis Tower's)!
Thank you to everyone who participated.
Interesting facts:
that is more than 1/2 ton
5 baby elephants
2 full grown dolphins
a male full grown alligator
a full grown quarter horse
or a Geo Metro!
When converting it to oreo's that 3,384,003 oreo's. Which equals 88,818.983 feet or 83 1/2 Effile towers :) or 59.9 Sears tower's (oops sorry Willis Tower's)!
Thank you to everyone who participated.
Sunday, July 26, 2009
Sunday, July 19, 2009
Some of the food
This is the first section of food from our recent food drive as you enter our office.
Saturday, July 18, 2009
Food drive 2009
I would like to thank everyone who participated in our 6th annual food drive for His Harvest Stand in Zeeland. We have not calculated the final count but I think this was our most successful food drive yet. This is a difficult time for them as many do not think if giving this time of year. With the kids home from school there is often more need. We feel blessed to have such wonderful practice members that allow us the opportunity to practice in this manner. When I have the final count on food I will post to share with everyone.
Thursday, July 2, 2009
Is Tylenol killing you?
Some days I am completely amazed at how far behind mainstream media can be. For years we have known Acetaminophen (Tylenol) is very damaging to the body. A study which came out approximately 10 years ago said it was the #1 reason for admittance to the hospital for acute kidney failure. Two days ago this report was on MSNBC.
If Tylenol is part of your morning "vitamin" routine you need to give us a call at 616.772.9255 or visit our website by clicking here.
Balanced Health Chiropractic Center
West Michigan's only NUCCA chiropractic office
Visit msnbc.com for Breaking News, World News, and News about the Economy
If Tylenol is part of your morning "vitamin" routine you need to give us a call at 616.772.9255 or visit our website by clicking here.
Balanced Health Chiropractic Center
West Michigan's only NUCCA chiropractic office
Monday, May 11, 2009
Wednesday, April 29, 2009
St. Louis NUCCA Conference
I just returned from nearly a week in St. Louis at the annual Spring conference. It was an amazing conference. To see what is happening in terms of research and advancement in NUCCA is unprecedented in the chiropractic world. The amazing thing about the advancement of NUCCA is that it has never been seen in the medical world prior to now either. The research happening now is validating what we have been saying for years. The only difference is now technology is catching up with what we have believed. Jim Palmer, one of our main sources in research as well as professor of physic at the University of Toledo, said, "Chiropractic and medicine have always been on opposite sides of the river with a bridge connecting us that is getting shorter. The only difference is that research is bringing them closer to us while we do what we have always done."
This is one of my favorite projects happening right now:
This is one of my favorite projects happening right now:
Using Phase Contrast MRI in migraine patients
A pilot study using Phase Contrast has recently concluded revealing startling evidence of changes in to cerebral blood flow after a NUCCA correction. The subject with a 20 year history of intractable headaches (migraine) occurring three to four times a week was studied. A PC MRA imaging study was obtained before the standardized NUCCA protocol evaluation. After the NUCCA procedure, a post PC MRA study was performed. The changes in venous outflow are represented graphically below.
Note in the post correction
graph, the venous outflow
has decreased.
For more information or to see if we can help you call us today at 616.772.9255.
Thursday, April 16, 2009
Thursday, April 2, 2009
Mandatory Vaccine?
We have all been seeing the marketing machine the pharmaceutical company, Merek, has put to work advertising their new vaccine Gardasil. I am not here to tell you what to do with your life and your health but I am here to give you information so that you can make an informed decision. Please, please, please watch the following videos before agreeing to the Gardasil vaccine.
This one is very straight forward from a radio interview in Texas where the governor is trying to pass a law making it mandatory for all girls to recieve this vaccine. I believe this is chemical assault to our children. Please watch.
If you have any questions feel free to email or call our office or visit Mercola.com for more great info. We are in no way affiliated with Mercola.com. It is a site I feel has a lot of wonderful information most people never hear.
This one is very straight forward from a radio interview in Texas where the governor is trying to pass a law making it mandatory for all girls to recieve this vaccine. I believe this is chemical assault to our children. Please watch.
If you have any questions feel free to email or call our office or visit Mercola.com for more great info. We are in no way affiliated with Mercola.com. It is a site I feel has a lot of wonderful information most people never hear.
Wednesday, April 1, 2009
Monday, March 30, 2009
The Chiropractic Pain Pill?
Have you ever gone to the chiropractor and after the first adjustment felt a little worse. In some cases, felt a lot worse. This may sound a little weird but my response is almost always, "Great!". Why do I want people to feel worse you may ask? Don't get me wrong, I do not like seeing my patients suffer. As a matter of fact I do not like seeing anyone suffer.
The body is a very simple, while at the same time complex, logical mechanism that responds in a very logical manner IF you understand what is happening. Exercise is a very good comparison. Have you ever decided to start and exercise routine? You get excited, jump in with both feet and really over do it. The next day you have a hard time getting out of bed and walking across the room. Your muscles are responding to the new stress placed on them and are going through their normal natural healing cycle.
Getting back to feeling worse after the first adjustment. Before the adjustment, your body was working in a distorted position that it had adapted to over a very long period of time. Soft tissues (ligaments, tendons, muscles) have all adapted to accommodate this new position. For a period of time your body can handle this distortion. Eventually this abnormal position causes inflammation, muscle tension, nerve distortion/irritation (subluxation) which changes the body even more. The result of the previous mentioned usually leads people to the office to take care of the problem. The "problem" is the distorted position in which the body is working and the result of that is pain.
Granted, everyone wants to be pain free. I hate pain as much as the next person and want it gone as quickly as possible. But, looking beyond the pain to what is causing the problem is the key. When the abnormal body is returned back to the "normal" position a lot of change happens. For example, certain muscles, ligaments, and tendons stretch, other muscles spasm to move the structures and hold them in place; joints work in a different manner than they had previously been. For some people this change can be dramatic. What I see is the longer they have been dealing with this problem the more change their body has to make.
Just like exercising, when your body gets use to the new stresses it no longer gets sore. It has adapted. The same is true with your body. When your body adapts to the correct way of working it now has a chance to heal the damaged areas and not just mask the symptoms temporarily. Time is key. It took a long time for your body to get in the shape it is in, it will not go away quickly.
The body is a very simple, while at the same time complex, logical mechanism that responds in a very logical manner IF you understand what is happening. Exercise is a very good comparison. Have you ever decided to start and exercise routine? You get excited, jump in with both feet and really over do it. The next day you have a hard time getting out of bed and walking across the room. Your muscles are responding to the new stress placed on them and are going through their normal natural healing cycle.
Getting back to feeling worse after the first adjustment. Before the adjustment, your body was working in a distorted position that it had adapted to over a very long period of time. Soft tissues (ligaments, tendons, muscles) have all adapted to accommodate this new position. For a period of time your body can handle this distortion. Eventually this abnormal position causes inflammation, muscle tension, nerve distortion/irritation (subluxation) which changes the body even more. The result of the previous mentioned usually leads people to the office to take care of the problem. The "problem" is the distorted position in which the body is working and the result of that is pain.
Granted, everyone wants to be pain free. I hate pain as much as the next person and want it gone as quickly as possible. But, looking beyond the pain to what is causing the problem is the key. When the abnormal body is returned back to the "normal" position a lot of change happens. For example, certain muscles, ligaments, and tendons stretch, other muscles spasm to move the structures and hold them in place; joints work in a different manner than they had previously been. For some people this change can be dramatic. What I see is the longer they have been dealing with this problem the more change their body has to make.
Just like exercising, when your body gets use to the new stresses it no longer gets sore. It has adapted. The same is true with your body. When your body adapts to the correct way of working it now has a chance to heal the damaged areas and not just mask the symptoms temporarily. Time is key. It took a long time for your body to get in the shape it is in, it will not go away quickly.
Sunday, March 29, 2009
Exciting Research Happening in NUCCA
Years of clinical evidence suggest that the atlas vertebra misalignment may be related to a negative impact on human nervous system function resulting in chronic health symptoms, conditions and diseases affecting a decrease of quality of life. Within the chiropractic profession, investigation and validation of the mechanisms involved in supporting theories on spinal misalignments are lacking and long overdue.
It has long been suspected that upper cervical spinal misalignments result in altered cerebral blood flow. Correction of the misalignment may produce a ‘normalization’ of blood flow and a reversal of related patient reported conditions (Scott R et al. 1-8). Accuracy and validity in noninvasive measurement of cerebral blood flow has been limited due to technology.
A new method using Phase Contrast Magnetic Resonance Imaging (MRI) Angiography (PC MRA) now exists that significantly increases accurate valid measurements. Using PC MRA, cerebral arterial and venous blood can be measured in almost every vessel in the brain with an added ability to measure cerebrospinal fluid flow and determine Intra-cranial Pressure (ICP).
It has been proposed to measure all these parameters using PC MRA before and after a NUCCA correction of the atlas misalignment. From these proposed pilot investigations, evidence of mechanisms detrimental to the central nervous system may be discovered.
Changes in cerebral blood flow have been demonstrated by medical research to be connected to a number of medically diagnosed conditions and diseases. With the appropriate tools now available, the effect of the NUCCA atlas correction procedure on cerebral blood flow can be accurately evaluated.
Two studies, each involving ten medically diagnosed patients with Stage I hypertension and ten medically diagnosed patients with migraine headaches are planned. Mechanisms already suspected in migraine headaches and hypertension may be related to in the brain stem nuclei, a critical area that may be involved in the atlas misalignment.
Measurable changes in cerebral blood and cerebrospinal fluid flow may substantiate a neural homeostatic mechanism affected by atlas misalignment in the brain stem nuclei. This research will lay the foundation for further research into the effect of the atlas misalignment on the central nervous system.
For more information visit: www.ucrf.org
It has long been suspected that upper cervical spinal misalignments result in altered cerebral blood flow. Correction of the misalignment may produce a ‘normalization’ of blood flow and a reversal of related patient reported conditions (Scott R et al. 1-8). Accuracy and validity in noninvasive measurement of cerebral blood flow has been limited due to technology.
A new method using Phase Contrast Magnetic Resonance Imaging (MRI) Angiography (PC MRA) now exists that significantly increases accurate valid measurements. Using PC MRA, cerebral arterial and venous blood can be measured in almost every vessel in the brain with an added ability to measure cerebrospinal fluid flow and determine Intra-cranial Pressure (ICP).
It has been proposed to measure all these parameters using PC MRA before and after a NUCCA correction of the atlas misalignment. From these proposed pilot investigations, evidence of mechanisms detrimental to the central nervous system may be discovered.
Changes in cerebral blood flow have been demonstrated by medical research to be connected to a number of medically diagnosed conditions and diseases. With the appropriate tools now available, the effect of the NUCCA atlas correction procedure on cerebral blood flow can be accurately evaluated.
Research Goals
The desired outcome of the blood flow investigations is two fold. Most significant is to discover neural mechanisms involved for two specific conditions involving a large population of our society: migraine headaches and hypertension. The second outcome will attract interest within the scientific community for further investigation of these mechanisms and the funding required to conduct the Gold Standard, Controlled Clinical Research Trials required for validation.Two studies, each involving ten medically diagnosed patients with Stage I hypertension and ten medically diagnosed patients with migraine headaches are planned. Mechanisms already suspected in migraine headaches and hypertension may be related to in the brain stem nuclei, a critical area that may be involved in the atlas misalignment.
Measurable changes in cerebral blood and cerebrospinal fluid flow may substantiate a neural homeostatic mechanism affected by atlas misalignment in the brain stem nuclei. This research will lay the foundation for further research into the effect of the atlas misalignment on the central nervous system.
For more information visit: www.ucrf.org
Do you feel lost?
Many times in life we all feel a little lost. Almost everyday I speak with someone who is currently dealing with feeling “lost”. They have tried everything. They went to their MD, who sent them to another MD to run tests. The tests return negative but are given a prescription anyway in the hopes it will work. Then they see a physical therapist 3x/week for 6-8 weeks while still taking the prescription their MD gave them. They go back to their MD stretched and stronger, on a prescription, and still has not gotten anywhere. They are sent to another MD who runs the same tests yet guess on another prescription and give something else to balance the effects of the first prescription.Does this sound familiar?
We see this almost everyday in our office. I feel it is sad. Many people have been going round and round in an effort to find help. They are trying to find a path back to health. I wish I kept track of the amount of people who said after they started care, “I wish I would have found you sooner!”, or “Why didn’t someone tell me about this before?”.
If you feel lost, call us. Schedule a no-charge consult. We will tell you if we can help, at the same time if we feel we cannot help we will tell you that as well and send you in different direction.
Dr. Stan Dombroski
Balanced Health Chiropractic Center.
Awake during surgery!
A very disturbing article was just released by the Associated Press stating a recent study finds 30,000 people a year wake during surgery! Click in the link to read the entire article…
http://www.msnbc.msn.com/id/23597612/wid/11915773
Autism linked to Vaccines!
Finally. The government has finally conceded the point that vaccines can and DO cause autism. Click or copy and paste into your browser the link below to read the article.
http://www.nationalautismassociation.org/press022808.php
This is something practitioners and believers of true health have been preaching for years. Much of the time it has fallen on deaf ears. As the old saying goes, “with time the truth be told.” Unfortunately, many suffer before the point is accepted. Please send this link to your family and friends. Let them read the facts and truths to make their own decision about these poisons being injected at will to our children. Let them know they have a choice without condemnation. Let the decision should be theirs and not someone else.
NUCCA chiropractor lowers blood pressure
Here is a link to a study from Dr. Marshall Dickholtz in Chicago demonstrating how a NUCCA spinal correction can lower blood pressure equivalent to 2 blood pressure medications. It makes sense when we understand that the body works properly when interference is removed and it can communicate with itself from the inside out as it was designed. Click on the link below to see the news report.Is your spine out of balance?
February 20, 2008 on 1:02 am | In Uncategorized | No CommentsMany people ask me “How can I be out of alignment and still feel good?”. We get that question or something quite similar very often. Often we are out of balance or subluxated from the day we are born.
Our body is an amazing thing. It is very good at adapting to a situation/condition to survive. Kids will express this as things such as colic, asthma, ear infections (all of which have cleared up by correcting their spine in our office), etc… Adults can have very similar issues but it will be called back pain, headaches, asthma, etc… If it gets bad enough it is given a different name; disc bulge/herniation, migraines, carpal tunnel, etc…
As you see, all through our lives we can suffer from the same subluxation, just given a different as as we get older. To get back to the original question about being out of alignment and feeling good, when I am asked that by my patients I like to reference our dentists. They did a wonderful job educating people to take care of their teeth and having regular dental visits to prevent cavities. Well, do you know someone who has had a cavity and didn’t know it. Of course! Mostly all of us have had a cavity at one time or another, some more than others. We all know what happens if we do not get it taken care of right away. We end up in a lot of pain, need lots of dental work and have to pay a lot of money. Before the pain started we had the cavity and it took a trip to our dentist to find it before it got bad.
The same is true for subluxations in chiropractic. We may be out of balance but adapting to that position. At the time we may feel fine but our bodies are slowly breaking down. Essentially, we are rotting from the inside out. If it gets bad enough we will start to have symptoms, but only if it has been there long enough. Just like the dentist being the only person to be able to find a cavity before it starts causing pain, a chiropractor is the only person to be able to find a subluxation, “spinal cavity” before it starts causing pain or problems. Have you visited your chiropractor lately? It may be time for a spinal check up.
Next time well talk about the question, “Is it true that once you go to a chiropractor you have to keep going?”.
Flu vaccine: friend or foe?
I’ve been saying for years the best way to catch the flu is to get the flu vaccine. Granted, the theory of vaccination is a plausible idea but has not lived up to its expectations of eradication of disease. Another article published in popular media today is just more evidence supporting what many “alternative” practitioners have believed for years.Flu season, and vaccine, looking worse
AP - 22 minutes ago
ATLANTA - The flu season is getting worse, and U.S. health officials say it’s partly because the flu vaccine doesn’t protect against most of the spreading flu bugs. The flu shot is a good match for only about 40 percent of this year’s flu viruses, officials at the U.S. Centers for Disease Control and Prevention said Friday.
* Video: Shot Not Preventing Many Flu Viruses WJZ 13 Baltimore
Here is the link to the entire article:
http://news.yahoo.com/s/ap/20080216/ap_on_he_me/flu_season;_ylt=Ak8J0Tug6l06XaVb3WzRFxas0NUE
The last line of the article states, “This represents a real increase in resistance,”. The question I have, is it really an increase of resistance of the “bug” or is it a decrease in the body’s ability to defend itself? Stress (physical, emotional), trauma (accidents, injuries), toxins (food preservatives, vaccine toxicity/preservatives, environmental factors) all decrease the body’s ability to defend itself.
- Dr Stan
Subscribe to:
Posts (Atom)